Kodiak Sciences (KOD) Depreciation and Depletion (2017 - 2026)
Kodiak Sciences (KOD) reported Depreciation and Depletion of $4.1 million for Q1 2026, down 10.73% on a YoY basis from $4.6 million in Q1 2025, and down 9.01% quarter-over-quarter from $4.5 million in Q4 2025.
Kodiak Sciences (KOD) Depreciation and Depletion (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Depreciation and Depletion for 10 years, with the latest figure at $4.1 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 10.73% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $17.8 million (down 4.32% YoY), and the FY2025 full-year result was $18.3 million, down 2.19% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $4.1 million, down from $4.5 million in the prior quarter.
- The five-year high for Depreciation and Depletion was $5.0 million in Q3 2023, with the low at $298000.0 in Q1 2022.
- Historically, Depreciation and Depletion has averaged $3.7 million across 5 years, with a median of $4.6 million in 2025.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion surged 1178.52% — and 2026, when it retreated 10.73%.
- Kodiak Sciences' Depreciation and Depletion stood at $1.6 million in 2022, then soared by 202.56% to $4.7 million in 2023, then retreated by 2.12% to $4.6 million in 2024, then declined by 2.38% to $4.5 million in 2025, then declined by 9.01% to $4.1 million in 2026.
- The last three Depreciation and Depletion figures came in at $4.1 million (Q1 2026), $4.5 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 4.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.11 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | 4.52 Mn |
| Dec 31, 2025 | 4.52 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Jun 30, 2025 | 4.59 Mn |
| Jun 30, 2025 | 4.59 Mn |
| Mar 31, 2025 | 4.60 Mn |
| Mar 31, 2025 | 4.60 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Sep 30, 2024 | 4.69 Mn |
| Sep 30, 2024 | 4.69 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | 4.73 Mn |
| Dec 31, 2023 | 4.73 Mn |